Display options
Cite
Shatoor AS, Zaki MS, Eid RA, et al. Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E. J Clin Med Res. 2012;4(3):190-6doi: 10.4021/jocmr909w.
Shatoor, A. S., Zaki, M. S., Eid, R. A., & Sayed-Ahmad, M. A. (2012). Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E. Journal of clinical medicine research, 4(3), 190-6. https://doi.org/10.4021/jocmr909w
Shatoor, Abdullah S, et al. "Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E." Journal of clinical medicine research vol. 4,3 (2012): 190-6. doi: https://doi.org/10.4021/jocmr909w
Shatoor AS, Zaki MS, Eid RA, Sayed-Ahmad MA. Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E. J Clin Med Res. 2012 Jun;4(3):190-6. doi: 10.4021/jocmr909w. Epub 2012 May 15. PMID: 22719805; PMCID: PMC3376877.
Copy Download .nbib Format: NLM
Share it on

J Clin Med Res. 2012 Jun;4(3):190-6. doi: 10.4021/jocmr909w. Epub 2012 May 15.

Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E.

Journal of clinical medicine research

Abdullah S Shatoor, Mohamed Samir Ahmad Zaki, Refaat A Eid, Mohamed A Sayed-Ahmad

Affiliations

  1. Internal Medicine Department, Cardiology Section, Faculty of Medicine, King Khalid University, Saudi Arabia.

PMID: 22719805 PMCID: PMC3376877 DOI: 10.4021/jocmr909w

Abstract

BACKGROUND: Amiodarone chlorhydrate is a diiodated benzofuran derivative used to treat a variety of cardiac rhythm abnormalities. The use of amiodarone is associated with ultrastructural changes affecting body tissues, but its effect on the ultrastructure of the heart has not yet been fully elucidated.

METHODS: The aim of this study is to test the adverse effects of amiodarone administration on cardiomyocytes and to study the possible protective role of vitamin E co-administration. A total of 18 adult male albino rats were used in this study. The rats were divided randomly into three groups of 6 rats each as follows: group I was considered the control group and was given vegetable oil; group II received 54 mg/kg of oral amiodarone; and group III received a single dose of combined vitamin E (50 mg/kg) and amiodarone (54 mg/kg). After 2 weeks, the rats were sacrificed, and the atrial tissues were harvested and processed for electron microscopic study.

RESULTS: ADMINISTRATION OF AMIODARONE ALONE MODIFIED THE ATRIAL ARCHITECTURE, WHICH WAS DEMONSTRATED BY THE FOLLOWING: mitochondrial enlargement and cristae lysis; marked heterogeneity of myofibril patterns with partial necrosis and disintegration of myofilaments; and irregularities of the sarcomere and less concentration of atrionatriuretic factor (ANF) granules, which localised in closed proximity to the nucleus with disrupted chromatin contents. Concomitant administration of vitamin E with amiodarone showed a considerable preservation of the atrial architecture.

CONCLUSIONS: Oral administration of amiodarone in rats resulted in ultrastructural changes in atria, which can be attenuated by vitamin E co-administration.

Keywords: Amiodarone; Cardiomyocytes; Electron microscopy

References

  1. Optometry. 2006 Feb;77(2):76-81 - PubMed
  2. J Pharmacol Exp Ther. 1990 Dec;255(3):1371-6 - PubMed
  3. Toxicology. 1999 Apr 15;133(2-3):75-84 - PubMed
  4. J Am Coll Cardiol. 1983 Dec;2(6):1114-28 - PubMed
  5. Exp Anim. 1996 Apr;45(2):125-33 - PubMed
  6. N Engl J Med. 1995 Jul 13;333(2):77-82 - PubMed
  7. Biochim Biophys Acta. 1998 Aug 10;1366(1-2):53-67 - PubMed
  8. Heart. 2006 Oct;92(10):1395 - PubMed
  9. J Vet Intern Med. 2000 Jan-Feb;14(1):90-5 - PubMed
  10. J Pharmacol Exp Ther. 2003 Jan;304(1):277-83 - PubMed
  11. J Cardiovasc Electrophysiol. 1993 Apr;4(2):161-77 - PubMed
  12. J Vet Med Sci. 1991 Aug;53(4):561-8 - PubMed
  13. Cardiovasc Res. 2001 Sep;51(4):736-48 - PubMed
  14. J Cardiovasc Pharmacol. 1988 Jul;12(1):23-36 - PubMed
  15. Circulation. 1999 Nov 9;100(19):2025-34 - PubMed
  16. J Pharmacol Exp Ther. 1990 Dec;255(3):1377-84 - PubMed
  17. J Am Coll Cardiol. 2001 Nov 15;38(6):1734-40 - PubMed
  18. Ann Intern Med. 1997 Jan 1;126(1):63-73 - PubMed
  19. Clin Exp Pharmacol Physiol. 1976 Sep-Oct;3(5):427-42 - PubMed
  20. Hum Pathol. 1990 Jan;21(1):59-67 - PubMed
  21. Clin Res Cardiol. 2010 Nov;99(11):693-700 - PubMed
  22. Jikken Dobutsu. 1992 Jul;41(3):321-8 - PubMed
  23. Lancet. 1994 Aug 20;344(8921):493-8 - PubMed
  24. Am J Physiol Heart Circ Physiol. 2004 Jun;286(6):H2169-82 - PubMed
  25. Saudi J Gastroenterol. 2009 Apr;15(2):104-10 - PubMed
  26. Circulation. 1991 Feb;83(2):504-14 - PubMed
  27. J Toxicol Sci. 1996 Nov;21(4):253-67 - PubMed
  28. Am Heart J. 1983 Oct;106(4 Pt 2):788-97 - PubMed
  29. Can J Physiol Pharmacol. 1994 Jun;72(6):613-21 - PubMed
  30. N Engl J Med. 1987 Feb 19;316(8):455-66 - PubMed
  31. Circulation. 1996 Jun 15;93(12):2128-34 - PubMed
  32. Circulation. 2001 Mar 6;103(9):1317-24 - PubMed
  33. Ann Intern Med. 1988 Nov 15;109(10):838-40 - PubMed
  34. J Nutr. 2002 Oct;132(10):3178-85 - PubMed
  35. Drug Saf. 2010 Jul 1;33(7):539-58 - PubMed
  36. J Hepatol. 2001 Nov;35(5):628-36 - PubMed
  37. J Clin Pharmacol. 1984 Apr;24(4):129-47 - PubMed
  38. Recent Adv Stud Cardiac Struct Metab. 1976;9:395-419 - PubMed

Publication Types